Position in INCY
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$3,905,980
-$192,975 QoQ
Shares Held
41,500
0.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
1.68%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Derivatives in INCY
reported options exposure · as of Dec 31, 2023CallValue
$62,790
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026DCF Advisers, LLC holds $55,922,160 across 20 Biotechnology names. INCY ranks #6 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
14,650 | $10,698,162 | |
| 2 | CRVS |
Corvus Pharmaceuticals, Inc.
|
637,500 | $9,326,625 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,250 | $7,146,920 | |
| 4 | NAMS |
NewAmsterdam Pharma Co N.V.
|
160,600 | $5,140,806 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
56,000 | $4,205,040 | |
| 6 | INCY |
Incyte Corp
This page
|
41,500 | $3,905,980 | |
| 7 | HELP |
Cybin Inc.
|
691,988 | $3,321,542 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,000 | $3,125,780 |
All Filings in INCY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,905,980 | 41,500 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,098,955 | 41,500 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,519,615 | 41,500 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,826,150 | 41,500 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,724,750 | 45,000 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $3,349,895 | 48,500 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,189,325 | 48,250 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,121,930 | 51,500 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,933,955 | 51,500 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,668,575 | 42,500 | Shares | Sole | 2024-02-13 | |
| 2023-12-31 | $62,790 | 1,000 | Call | Sole | 2024-02-13 | |
| 2023-09-30 | $2,570,765 | 44,500 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,521,125 | 40,500 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,071,475 | 42,500 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,534,080 | 44,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,932,160 | 44,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,342,680 | 44,000 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,613,610 | 45,500 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,138,000 | 70,000 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $343,900 | 5,000 | Call | Sole | 2021-11-15 | |
| 2021-09-30 | $4,814,600 | 70,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,131,930 | 61,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,282,550 | 65,000 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $5,436,250 | 62,500 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,384,400 | 60,000 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,082,245 | 58,500 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,379,154 | 59,800 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||